Cellbricks envisions a future where 3D-bioprinting of human tissue and organs is a common medical practice
Cellbricks is at the forefront of biotechnology, dedicated to revolutionizing healthcare through the innovative application of 3D-bioprinting. With a vision of making bioprinted human tissue and organs a common medical practice, Cellbricks is committed to significantly impacting the lives of patients facing compromised organ function. The company achieves this by producing cutting-edge bioprinted tissue therapeutics, striving to enhance and extend human lives through the restoration and support of vital organ functions. The primary address of Cellbricks is Müllerstrasse 178, c/o Campus of Bayer AG, Berlin, 13353, DE.
Combining world-leading expertise in synthetic biology and 3D-bioprinting, Cellbricks leverages its proprietary biofabrication technology and tissue engineering proficiency to replicate human tissue at scale. This allows researchers and doctors to provide patients with enhanced clinical treatments, pushing the boundaries of what's possible in regenerative medicine. Cellbricks is dedicated to advancing tissue engineering, biologics, and pharma through groundbreaking research and development.
Cellbricks is rapidly expanding and continues to welcome new collaborations and opportunities. The company is committed to pushing the boundaries of biotechnology and providing patients with better clinical treatments. To the management of Cellbricks: We invite you to create a customized and exclusive company showcase and product listing on our platform, to further enhance your commercial development and reach.
Cellbricks est à l'avant-garde de la biotechnologie, dédiée à révolutionner les soins de santé grâce à l'application innovante de la bio-impression 3D. Avec une vision de faire du bio-impression de tissus et d'organes humains une pratique médicale courante, Cellbricks s'engage à avoir un impact significatif sur la vie des patients confrontés à une fonction organique compromise. L'entreprise y parvient en produisant des thérapies tissulaires bio-imprimées de pointe, s'efforçant d'améliorer et de prolonger la vie humaine grâce à la restauration et au soutien des fonctions organiques vitales. L'adresse principale de Cellbricks est Müllerstrasse 178, c/o Campus de Bayer AG, Berlin, 13353, DE.
Combinant une expertise de pointe en biologie synthétique et en bio-impression 3D, Cellbricks exploite sa technologie de biofabrication exclusive et ses compétences en ingénierie tissulaire pour reproduire des tissus humains à grande échelle. Cela permet aux chercheurs et aux médecins de fournir aux patients des traitements cliniques améliorés, repoussant les limites du possible en médecine régénérative. Cellbricks se consacre à faire progresser l'ingénierie tissulaire, les produits biologiques et la pharmacie grâce à la recherche et au développement révolutionnaires.
Cellbricks est en pleine expansion et continue d'accueillir de nouvelles collaborations et opportunités. L'entreprise s'engage à repousser les limites de la biotechnologie et à fournir aux patients de meilleurs traitements cliniques. À la direction de Cellbricks : Nous vous invitons à créer une vitrine d'entreprise et une liste de produits personnalisées et exclusives sur notre plateforme, afin d'améliorer encore votre développement commercial et votre portée.
Compare Cellbricks with 3 companies in Biotechnology
| Comparison Field |
CellbricksMain Company |
BICOView Profile |
Globe Biotech Limite...View Profile |
Vo
VoxCell BioInnovatio...View Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 0 | 2016 | 2020 |
|
Company Size
|
— | 1,001-5,000 | 51-200 | 11-50 |
|
City
|
Kallebäck, Västra Götaland County | Dhaka, Dhaka | Victoria, BC | |
|
Country
|
Sweden | Bangladesh | Canada | |
|
Skills & Keywords
Comparing with main company
|
23 Total Skills
3D Bioprinting
Tissue Engineering
Biotechnology
Regenerative Medicine
Biofabrication
Biologics
Pharma
Tissue engineering
Lifesciences
Stereolithography
TechBio
LabModels
Regenerative medicine
Implants
Bioink
Autologous Tissue Implants
Oncology
Recombinant Collagen
HealthTech
Breast cancer
Breast Reconstruction
Human Tissue
tissue therapeutics
|
10 Total
10 Unique
Unique Skills:
3D printing
Biomaterials
Biomedicine
Bioprinting
Bioprinting research
Biotech
+4
|
13 Total
13 Unique
Unique Skills:
APIs
Bacterial Cell Culture
Biosimilar
Cell Biology
Drug Formulation
Master Cell Bank
+7
|
11 Total
1 Common
10 Unique
Match
4%
Common Skills:
Tissue Engineering
Unique Skills:
3D Printing
Biopharma
Bioprinting
Cancer
Drug Development
Personalized Medicine
+4
|
Other organizations in the same industry
This company is also known as